Progress of clinical medication for differentiated thyroid carcinoma / 医学研究生学报
Journal of Medical Postgraduates
;
(12): 544-549, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-700870
ABSTRACT
The main treatment model for differentiated thyroid cancer is surgery -based individualized treatment .Due to the in-ert cancer characteristics of DTC , drug therapies such as thyrotropin suppressive therapy , molecular targeted therapy, neoadjuvant chemotherapy and Chinese medicine treatment have become the current research hotspots .Here, we reviewed the progress of clinical medication for DTC to improve the understanding of DTC drug therapy .
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio pronóstico
Idioma:
Chino
Revista:
Journal of Medical Postgraduates
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS